A Phase 1 Pharmacokinetic/Pharmacodynamic Study of Oral Beclomethasone 17,21-Dipropionate (BDP) in Healthy Adolescents and Young Adults

Trial Profile

A Phase 1 Pharmacokinetic/Pharmacodynamic Study of Oral Beclomethasone 17,21-Dipropionate (BDP) in Healthy Adolescents and Young Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2013

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Crohn's disease
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 Jun 2013 Results have been reported briefly in a Soligenix media release.
    • 28 Jun 2013 Status changed from recruiting to completed, according to a Soligenix media release.
    • 16 May 2013 Status changed from not yet recruiting to recruiting, as reportd by a Soligenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top